Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hepatitis B Flare in Hepatitis B e Antigen-Negative Patients: A Complicated Cascade of Innate and Adaptive Immune Responses
Ming‐Ling Chang, Yun‐Fan Liaw
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1552-1552
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Hepatitis E Virus (HEV) Infection Among Immunocompromised Individuals: A Brief Narrative Review
Radostina Alexandrova, Ilia Tsachev, Plamen M. Kirov, et al.
Infection and Drug Resistance (2024) Vol. Volume 17, pp. 1021-1040
Open Access | Times Cited: 9
Screening of crosstalk and pyroptosis-related genes linking periodontitis and osteoporosis based on bioinformatics and machine learning
Jia Liu, Ding Zhang, Yu Cao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 32
Hepatitis B functional cure and immune response
Jia-Rui Zheng, Zilong Wang, Bo Feng
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 32
Emerging Therapies for Chronic Hepatitis B and the Potential for a Functional Cure
Ming‐Ling Chang, Yun‐Fan Liaw
Drugs (2023) Vol. 83, Iss. 5, pp. 367-388
Closed Access | Times Cited: 12
Dynamic Changes of Cytokine Profiles and Virological Markers Associated With HBsAg Loss During Peginterferon Alpha-2a Treatment in HBeAg-Positive Chronic Hepatitis B Patients
Minghui Li, Luxue Zhang, Si Xie, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13
Hepatic and Extrahepatic Characteristics of Autoimmune Hepatitis: A 23-year Hospital-Based Cohort Study
Ming‐Ling Chang, Puo‐Hsien Le, Wei‐Ting Chen, et al.
Digestive Diseases and Sciences (2024) Vol. 69, Iss. 6, pp. 2193-2203
Closed Access | Times Cited: 2
Early HBcrAg and Anti‐HBc Levels Identify Patients at High Risk for Severe Flares After Nucleos(t)ide Analogue Cessation—A Pooled Analysis of Two Clinical Trials
Edo J. Dongelmans, Jordan J. Feld, André Boonstra, et al.
Alimentary Pharmacology & Therapeutics (2024)
Open Access | Times Cited: 2
Hepatitis B flare: the good, the bad and the ugly
Yun‐Fan Liaw
Expert Review of Gastroenterology & Hepatology (2022) Vol. 16, Iss. 11-12, pp. 1043-1051
Closed Access | Times Cited: 9
Follow-up value of serum AFP and aminotransferases in chronic hepatitis B progression
Mengyao Yu, Lei Huang, Shi-Chang Zhang, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 4
Development of Therapy Based on the Exploration of Biological Events Underlying the Pathogenetic Mechanisms of Chronic Hepatitis B Infection
Sheikh Mohammad Fazle Akbar, Mamun Al Mahtab, Osamu Yoshida, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 1944-1944
Open Access | Times Cited: 4
The Relationship between Viral Replication and the Severity of Hepatic Necroinflammatory Damage Changed before HBeAg Loss in Patients with Chronic Hepatitis B Virus Infection
Leijie Wang, Jian Wang, Kunyu Zhao, et al.
Journal of Clinical and Translational Hepatology (2024) Vol. 12, Iss. 4, pp. 381-388
Open Access | Times Cited: 1
The Comparison of Serum Interleukin-8 Levels Based on Severity of Liver Cirrhosis
Imelda Rey, Rustam Effendi-Ys, Khairani Sukatendel
Medical Archives (2024) Vol. 78, Iss. 2, pp. 92-92
Open Access | Times Cited: 1
Dysregulation in the microbiota by HBV and HCV infection induces an altered cytokine profile in the pathobiome of infection
Marcos Daniel Mendes Padilha, Francisco Tiago de Vasconcelos Melo, Rogério Valois Laurentino, et al.
The Brazilian Journal of Infectious Diseases (2024) Vol. 29, Iss. 1, pp. 104468-104468
Open Access | Times Cited: 1
Rheumatoid factor levels indicate cryoglobulinemia severity in hepatitis B e antigen-negative hepatitis B virus carriers: a 7-year prospective cohort study
J Wu, Wei-Ting Chen, Chung‐Guei Huang, et al.
Hepatology International (2024) Vol. 19, Iss. 1, pp. 118-130
Closed Access | Times Cited: 1
Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study Followed Up to 28 Years
Ming‐Ling Chang, Wei‐Ting Chen, Tien‐Ming Chan, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 7
Hepatitis C Virus Reactivation in Anti-HCV Antibody-Positive Patients with Chronic Hepatitis B Following Anti-HBV Therapies
Yi-Tse Su, Ming‐Ling Chang, Rong‐Nan Chien, et al.
Viruses (2022) Vol. 14, Iss. 9, pp. 1858-1858
Open Access | Times Cited: 7
Evaluation of the Diagnostic Performances of the SD-Bioline®HBeAg Rapid Test Used Routinely for the Management of HBV-Infected Individuals in Burkina Faso
Abdoulaye Dera, Armel Moumouni Sanou, Mathuola Nina Genéviève Ouattara, et al.
Diagnostics (2023) Vol. 13, Iss. 19, pp. 3144-3144
Open Access | Times Cited: 3
Bacterial Infections Confer a Risk of Progression to Acute-on-Chronic Liver Failure in Patients with HBV-Related Compensated Cirrhosis During Severe Hepatitis Flares
Jun Chu, Yanqing Yang, Yujuan Liu, et al.
Infectious Diseases and Therapy (2022) Vol. 11, Iss. 5, pp. 1839-1851
Open Access | Times Cited: 5
Study on pathological and clinical characteristics of chronic HBV infected patients with HBsAg positive, HBV DNA negative, HBeAg negative
Zhan Zeng, Ruyu Liu, Weihua Cao, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 2
Comparable outcomes of decompensated chronic hepatitis B patients treated with entecavir or tenofovir: an 8-year cohort study
Kuan‐Chieh Lee, Jur‐Shan Cheng, Ming‐Ling Chang, et al.
Hepatology International (2022) Vol. 16, Iss. 4, pp. 799-806
Closed Access | Times Cited: 4
Effective Analysis of Antiviral Treatment in Patients with HBeAg-Seropositive Chronic Hepatitis B with ALT < 2 Upper Limits of Normal: A Multi-center Retrospective Cohort Study
Meixin Hu, Guichan Liao, Sufang Wei, et al.
Infectious Diseases and Therapy (2023) Vol. 12, Iss. 2, pp. 637-647
Open Access | Times Cited: 2
Robust antiviral responses in severe hepatitis flare persist after early retreatment cessation and lead toward hepatitis B surface antigen loss: A proof‐of‐concept study
Ming‐Ling Chang, Rong‐Nan Chien, Yun‐Fan Liaw
Hepatology Research (2022) Vol. 52, Iss. 10, pp. 817-823
Open Access | Times Cited: 3
Study on liver histopathology of chronic HBV infected patients with different normal ALT values
Zhan Zeng, Hongxiao Hao, Xiaoyue Bi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 3
Withdrawal reaction from Janus kinase inhibitor manifesting as hepatitis B virus outbreak: a case report
Fenglin Zhu, N Liu, Xuhong Zhang, et al.
Scandinavian Journal of Rheumatology (2024), pp. 1-3
Open Access
Peripheral NK cell phenotypic alteration and dysfunctional state post hepatitis B subviral particles stimulation in CHB patients: evading immune surveillance
Mohamed Selim, Reda A. Suef, Ebrahim Saied, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Page 1 - Next Page

Scroll to top